MEDI-545: Clinical Trials

5 trials of MEDI-545, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

5 completed. 3 Phase 2, 2 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	3	Completed 3
Phase 1	2	Completed 2

Follow MEDI-545: new trials by email Literature Review of MEDI-545 trials Research Report on MEDI-545

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus Sifalimumab 200 mg, Sifalimumab 600 mg, Sifalimumab 1,200 mg - Systemic Lupus Erythematosus	Phase 2	Completed	MedImmune LLC	834	2011-03-31	2018-04-19
A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. MEDI-545, MEDI-545 600 - Systemic Lupus Erythematosus	Phase 2	Completed	AstraZeneca	30	2009-11-25	2018-11-19
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus MEDI-545, Placebo - Lupus Erythematosus, Systemic, Lupus	Phase 2	Completed	MedImmune LLC	87	2008-07-01	2016-08-09
A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis MEDI-545, Placebo - DERMATOMYOSITIS OR POLYMYOSITIS	Phase 1	Completed	MedImmune LLC	51	2008-04-01	2012-05-28
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) MEDI-545, MEDI 545 - Lupus	Phase 1	Completed	MedImmune LLC	45	2006-03-01	2007-12-18

Conditions studied

Sponsors

Countries

Top investigators

Results publications